Your browser doesn't support javascript.
loading
Can we consider cesarean myomectomy as a safe procedure without long-term outcome?
Akkurt, Mehmet Ozgur; Yavuz, And; Eris Yalcin, Serenat; Akkurt, Iltac; Turan, Ozerk Turel; Yalcin, Yakup; Sezik, Mekin.
Afiliação
  • Akkurt MO; a Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Perinatology , Suleyman Demirel University , Isparta , Turkey.
  • Yavuz A; a Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Perinatology , Suleyman Demirel University , Isparta , Turkey.
  • Eris Yalcin S; a Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Perinatology , Suleyman Demirel University , Isparta , Turkey.
  • Akkurt I; b Isparta Maternity and Children's Hospital, Department of Obstetrics and Gynecology , Isparta , Turkey , and.
  • Turan OT; c College of Arts and Sciences, University of Miami , Coral Gables , FL , USA.
  • Yalcin Y; a Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Perinatology , Suleyman Demirel University , Isparta , Turkey.
  • Sezik M; a Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Perinatology , Suleyman Demirel University , Isparta , Turkey.
J Matern Fetal Neonatal Med ; 30(15): 1855-1860, 2017 Aug.
Article em En | MEDLINE | ID: mdl-27550524
AIM: To investigate short- and long-term outcomes in women undergoing cesarean myomectomy (CM). METHODS: This was a retrospective study that explored short-term outcomes of women, who underwent cesarean operations with or without myomectomies (CM controls) in a single tertiary center throughout a 6-year-period. For long-term outcomes, the mean duration of follow-up was 6.3 ± 1.0 years. RESULTS: There were no differences among the CM (n= 91) and control groups (n = 60) considering mean change in hemoglobin and hematocrit levels, hemorrhage, as well as requirement for blood transfusions with a slightly increased operative time. Multiple myomas, and cervical and cornual localization were associated with an increased drop of hemoglobin and hematocrit (p < 0.05). Subsequent pregnancy and recurrence rates were 35% (32/91) and 5.5% (5/91), respectively. Preterm delivery (n = 1, 3.1%), uterine dehiscence (n = 1, 3.1%), placenta previa (n = 1, 3.1%) and mild-to-severe post-CM adhesions (n = 8, 25%) were observed in subsequent pregnancies. Recurrence was identified in five of the nonpregnant (5.5%) women, and three of these (4.1%) underwent an additional major surgery. There was no recurrence in subsequent pregnancies. CONCLUSION: The recurrence of myoma was relatively low following CM. Subsequent pregnancy is protective for recurrence of myoma without increased adhesion formation and obstetric complications.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cesárea / Resultado do Tratamento / Miomectomia Uterina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Pregnancy Idioma: En Revista: J Matern Fetal Neonatal Med Assunto da revista: OBSTETRICIA / PERINATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Turquia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cesárea / Resultado do Tratamento / Miomectomia Uterina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Pregnancy Idioma: En Revista: J Matern Fetal Neonatal Med Assunto da revista: OBSTETRICIA / PERINATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Turquia País de publicação: Reino Unido